These results demonstrated again a differential response of the three different melanoma variants to ALDOC and suggested that the ALDOC‐mediated up‐ or downregulation of ICAM‐1 may underlie the increased or decreased adhesion of melanoma cell lines to BEC. The gene discussed is ICAM1; the disease is melanoma.